Position
Chief Executive Officer
Company
858 Therapeutics
Description
858 Therapeutics has announced the appointment of Dr. Srini Ramanathan as Chief Executive Officer. He will lead the company into its next phase of growth, leveraging his extensive experience in drug development.
Quick answer
858 Therapeutics Appoints Dr. Srini Ramanathan as Chief Executive Officer (November 16, 2026). 858 Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Executive Officer at 858 Therapeutics?
- 858 Therapeutics named Srini Ramanathan Chief Executive Officer, announced November 16, 2026.
- What did 858 Therapeutics announce on November 16, 2026?
- 858 Therapeutics has announced the appointment of Dr. Srini Ramanathan as Chief Executive Officer. He will lead the company into its next phase of growth, leveraging his extensive experience in drug development.
- What does 858 Therapeutics do?
- 858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecules directed against novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune...
- Where is 858 Therapeutics based?
- 858 Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Nomad Power Solutions, Inc. (November 10, 2026), Thermo Fisher Scientific (October 30, 2026), Cardiff Oncology (October 27, 2026) and Intellia Therapeutics, Inc. (October 18, 2026) also announced leadership changes within 45 days of 858 Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Nomad Power Solutions Appoints Michael Hilmer as Consultant Following CEO Departure (November 10, 2026)
- Michael D. Shafer to Retire from Thermo Fisher Scientific (October 30, 2026)
- Cardiff Oncology Appoints Dr. Leila Alland as Interim Chief Medical Officer (October 27, 2026)
- Intellia Therapeutics Appoints Jing L. Marantz as Chief Medical Officer (October 18, 2026)
- Hain Celestial Appoints Patricia Ferrari and Richard Shinder as New Directors (October 15, 2026)
- Enliven Therapeutics Appoints Kristine Ball as Class II Director (October 14, 2026)
Who to call at 858 Therapeutics, and when
A new leader at 858 Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day 858 Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at 858 Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at 858 Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment 858 Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
858 Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.